Effect of acetazolamide on cytokines in rats exposed to high altitude

被引:18
|
作者
Wang, Chang [1 ,2 ]
Wang, Rong [1 ,2 ]
Xie, Hua [1 ]
Sun, Yuhuan [1 ,2 ]
Tao, Rui [1 ,2 ]
Liu, Wenqing [3 ]
Li, Wenbin [1 ,2 ]
Lu, Hui [1 ,2 ]
Jia, Zhengping [1 ,2 ]
机构
[1] Lanzhou Gen Hosp, PLA Key Lab Plateau Environm Damage Control, Lanzhou Command, Lanzhou 730050, Peoples R China
[2] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China
[3] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730030, Peoples R China
基金
中国国家自然科学基金;
关键词
Cytokine; High altitude; Hypoxia; Acetazolamide; INFLAMMATORY RESPONSE; ALVEOLAR MACROPHAGES; INTERMITTENT HYPOXIA; HYPOBARIC HYPOXIA; OXIDATIVE STRESS; EXERCISE; CELLS; PATHWAY; MATTER; INJURY;
D O I
10.1016/j.cyto.2016.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute mountain sickness (AMS) is a dangerous hypoxic illness that can affect humans who rapidly reach a high altitude above 2500 m. In the study, we investigated the changes of cytokines induced by plateau, and the acetazolamide (ACZ) influenced the cytokines in rats exposed to high altitude. Wistar rats were divided into low altitude (Control), high altitude (HA), and high altitude + ACZ (22.33 mg/kg, Bid) (HA + ACZ) group. The rats were acute exposed to high altitude at 4300 m for 3 days. The HA + ACZ group were given ACZ by intragastric administration. The placebo was equal volume saline. The results showed that hypoxia caused the heart, liver and lung damage, compared with the control group. Supplementation with ACZ significantly alleviated hypoxia-caused damage to the main organs. Compared with the HA group, the biochemical and blood gas indicators of the HA + ACZ group showed no difference, while some cytokines have significantly changed, such as activin A, intercellular adhesion molecule-1 (ICAM-1, CD54), interleukin-la,2 (1-1 alpha,2), L-selectin, monocyte chemotactic factor (MCP-1), CC chemokines (MIP-3 alpha) and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1). Then, the significant difference pro inflammatory cytokines in protein array were chosen for further research. The protein and mRNA content of pro-inflammatory cytokines MCP-1, interleukin-1 beta(IL-1 beta), tumor necrosis factor (TNF-alpha, interferon-gamma (IFN-gamma) in rat lung were detected. The results demonstrated that the high altitude affected the body's physiological and biochemical parameters, but, ACZ did not change those parameters of the hypoxia rats. This study found that ACZ could decrease the content of pro -inflammatory cytokines, such as MCP-1,IL -1 beta, TNF-alpha and IFN-y in rat lungs, and, the lung injury in the HA + ACZ group reduced. The mechanism that ACZ protected hypoxia rats might be related to changes in cytokine content. The reducing of the pro-inflammatory cytokines in rat lung might be other reason to explain ACZ against the acute mountain sickness. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:110 / 117
页数:8
相关论文
共 50 条
  • [21] Protective Effect of Ginkgolide B on High Altitude Cerebral Edema of Rats
    Yu Botao
    Ma, Jie
    Xiao, Wenjing
    Xiang, Qingyu
    Fan, Kaihua
    Hou, Jun
    Wu, Juan
    Jing, Weihua
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2013, 14 (01) : 61 - 64
  • [22] Effect of high-altitude hypoxia on function and cytoarchitecture of rats’ liver
    Elwathiq Ibrahim
    Shahzada Khalid Sohail
    Amadi Ihunwo
    Refaat A Eid
    Yazeed Al-Shahrani
    Assad Ali Rezigalla
    Scientific Reports, 15 (1)
  • [23] Long-Term Intermittent Exposure to High Altitude Elevates Asymmetric Dimethylarginine in First Exposed Young Adults
    Lueneburg, Nicole
    Siques, Patricia
    Brito, Julio
    Jose De La Cruz, Juan
    Leon-Velarde, Fabiola
    Hannemann, Juliane
    Ibanez, Cristian
    Boeger, Rainer H.
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2017, 18 (03) : 226 - 233
  • [24] Steady-state chemoreflex drive captures ventilatory acclimatization during incremental ascent to high altitude: Effect of acetazolamide
    Cates, Valerie C.
    Bruce, Christina D.
    Marullo, Anthony L.
    Isakovich, Rodion
    Saran, Gurkarn
    Leacy, Jack K.
    O'Halloran, Ken D.
    Brutsaert, Thomas D.
    Sherpa, Mingma T.
    Day, Trevor A.
    PHYSIOLOGICAL REPORTS, 2022, 10 (23):
  • [25] Protective effect of 5,6,7,8-Tetrahydroxyflavone on high altitude cerebral edema in rats
    Jing, Linlin
    Wu, Ningzi
    Zhang, Jie
    Da, Qingyue
    Ma, Huiping
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 928
  • [26] Exercise Limitation of Acetazolamide at Altitude (3459 m)
    Bradwell, Arthur R.
    Myers, Stephen D.
    Beazley, Maggie
    Ashdown, Kimberly
    Harris, Nick G.
    Bradwell, Susie B.
    Goodhart, Jamie
    Imray, Chris H.
    Wimalasena, Yashvi
    Edsell, Mark E.
    Pattinson, Kyle T. S.
    Wright, Alex D.
    Harris, Stephen J.
    WILDERNESS & ENVIRONMENTAL MEDICINE, 2014, 25 (03) : 272 - 277
  • [27] Altitude effect on Propofol Pharmacokinetics in Rats
    Li, Lijun
    Wang, Xuejun
    Wang, Sheng
    Li, Wen
    Zhang, Haopeng
    CURRENT DRUG METABOLISM, 2024, 25 (01) : 81 - 90
  • [28] Analysis of Retinal Segmentation Changes at High Altitude With and Without Acetazolamide
    Clarke, Alexander Kenneth
    Cozzi, Mariano
    Imray, Christopher Henry Ernest
    Wright, Alex
    Pagliarini, Sergio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (01) : 36 - 40
  • [29] Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness
    Phillips, Lara
    Basnyat, Buddha
    Chang, Yuchiao
    Swenson, Erik R.
    Harris, N. Stuart
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2017, 18 (02) : 121 - 127
  • [30] Nocturnal cerebral oxygenation in patients with COPD at altitude - effect of acetazolamide
    Schmuziger, Yael Anne
    Mademilov, Maamed
    Buergin, Aline
    Scheiwiller, Philipp M.
    Mayer, Laura
    Schneider, Simon R.
    Lichtblau, Mona
    Bitos, Konstantinos
    Muralt, Lara
    Groth, Alexandra
    Sheraliev, Ulan
    Marazhapov, Nuriddin H.
    Akylbekov, Azamat
    Mirzalieva, Gulzada
    Oleinik, Alena
    Sooronbaev, Talant M.
    Ulrich, Silvia
    Bloch, Konrad E.
    Furian, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58